As well as playing a critical role in CD8+ T-cell immunity, the TCR/pMHCI interaction can result in inappropriate CD8+ T-cell activity in situations such as autoimmunity, hematological disorders, and transplant rejection (alloreactivity). This evidence concerns the gene CD8A and hematologic disorder.